Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor
2000

Effect of a fluorinated pyrimidine on cachexia and tumor growth

publication

Author Information

Author(s): Hussey H J, Todorov P T, Field W N, Inagaki N, Tanaka Y, Ishitsuka H, Tisdale M J

Primary Institution: Pharmaceutical Sciences Research Institute, Aston University, Birmingham, B4 7ET, UK

Hypothesis

The study investigates the relationship between a fluorinated pyrimidine and cachexia in murine models.

Conclusion

The fluorinated pyrimidine 5′-dFUrd can reduce cachexia and tumor growth in certain cancer models by eliminating a proteolysis-inducing factor.

Supporting Evidence

  • 5′-dFUrd reduced cachexia in murine adenocarcinomas MAC16 and colon 26.
  • The presence of a proteolysis-inducing factor (PIF) was linked to cachexia in the MAC16 model.
  • Treatment with 5′-dFUrd eliminated PIF from the tumor, serum, and urine in mice with cachexia.

Takeaway

A special medicine helped mice with cancer not lose weight and grow tumors slower by getting rid of a harmful factor in their bodies.

Methodology

The study used murine models of adenocarcinomas and measured the effects of 5′-dFUrd on cachexia and tumor growth.

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1278

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication